Signals flagged in the original
Provisional estimate — refines shortly Full breakdown ↓
A study has found that tirzepatide, a weight loss drug, may help reduce symptoms of sleep apnoea in patients, with up to half experiencing remission. The review highlighted significant improvements in breathing and snoring among participants, although researchers emphasized that these drugs should not replace CPAP therapy for severe cases.
Our neutral summary
A study has found that tirzepatide, a weight loss drug, may help reduce symptoms of sleep apnoea in patients, with up to half experiencing remission. The review highlighted significant improvements in breathing and snoring among participants, although researchers emphasized that these drugs should not replace CPAP therapy for severe cases.
The reporting belongs to Daily Mail; we don't reproduce it.
No note attached
on this article.
Yet another benefit of weight loss jabs: They combat severe snoring, study finds
Study Finds Weight Loss Drugs May Help Combat Severe Snoring and Sleep Apnoea